Hasil Pencarian - Mulan Chen

  • Menampilkan 1 - 7 hasil dari 7
Perbaiki Hasil
  1. 1
    Cost-effectiveness of utidelone and capecitabine versus monotherapy in anthracycline- and taxane-refractory metastatic breast cancer

    Cost-effectiveness of utidelone and capecitabine versus monotherapy in anthracycline- and taxane-refractory metastatic breast cancer oleh Mulan Chen, Heng Zhang, Xiaoyan He, Yingtao Lin

    Diterbitkan 2024-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Lack of interferon regulatory factor 3 leads to anxiety/depression-like behaviors through disrupting the balance of neuronal excitation and inhibition in mice

    Lack of interferon regulatory factor 3 leads to anxiety/depression-like behaviors through disrupting the balance of neuronal excitation and inhibition in mice oleh Junjie Li, Yayan Pang, Yehong Du, Lei Xia, Mulan Chen, Yepeng Fan, Zhifang Dong

    Diterbitkan 2023-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Gradient differences of immunotherapy efficacy in metastatic melanoma related to sunlight exposure pattern: A population-based study

    Gradient differences of immunotherapy efficacy in metastatic melanoma related to sunlight exposure pattern: A population-based study oleh Mengsong Liu, Mengsong Liu, Wenyuan Li, Xiao Ma, Yuhui Che, Yuhui Che, Bo Wei, Bo Wei, Mulan Chen, Mulan Chen, Lin Zhong, Lin Zhong, Siqi Zhao, Siqi Zhao, Anjing Chen, Anjing Chen, Yaobin Pang, Yaobin Pang, Jinhao Zeng, Jinhao Zeng, Jing Guo, Jing Guo

    Diterbitkan 2023-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    EZH2 mutation is associated with the development of visceral metastasis by enhancing proliferation and invasion and inhibiting apoptosis in breast cancer cells

    EZH2 mutation is associated with the development of visceral metastasis by enhancing proliferation and invasion and inhibiting apoptosis in breast cancer cells oleh Fan Wu, Nani Li, Xiufeng Wu, Mulan Chen, Weiwei Huang, Xinhua Chen, Yi Hong, Lili Wang, Kan Chen, Lin Lin, Minjin You, Jian Liu

    Diterbitkan 2024-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    A real-world study of the effectiveness and safety of apatinib-based regimens in metastatic triple-negative breast cancer

    A real-world study of the effectiveness and safety of apatinib-based regimens in metastatic triple-negative breast cancer oleh Weiwei Huang, Chenxi Wang, Yangkun Shen, Qi Chen, Zhijian Huang, Jian Liu, Xiaoyan Lin, Lili Wang, Fan Wu, Xinhua Chen, Nani Li, Yi Hong, Mulan Chen, Jieyu Li, Chuanzhong Huang

    Diterbitkan 2024-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Correction: A real-world study of the effectiveness and safety of apatinib-based regimens in metastatic triple-negative breast cancer

    Correction: A real-world study of the effectiveness and safety of apatinib-based regimens in metastatic triple-negative breast cancer oleh Weiwei Huang, Chenxi Wang, Yangkun Shen, Qi Chen, Zhijian Huang, Jian Liu, Xiaoyan Lin, Lili Wang, Fan Wu, Xinhua Chen, Nani Li, Yi Hong, Mulan Chen, Jieyu Li, Chuanzhong Huang

    Diterbitkan 2024-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Feasibility and tolerability of eribulin-based chemotherapy versus other chemotherapy regimens for patients with metastatic triple-negative breast cancer: a single-centre retrospective study

    Feasibility and tolerability of eribulin-based chemotherapy versus other chemotherapy regimens for patients with metastatic triple-negative breast cancer: a single-centre retrospec... oleh Weiwei Huang, Weiwei Huang, Weiwei Huang, Chenxi Wang, Lili Wang, Yangkun Shen, Qi Chen, Zhijian Huang, Jian Liu, Xiaoyan Lin, Xiaoyan Lin, Fan Wu, Xinhua Chen, Nani Li, Yi Hong, Mulan Chen, Jieyu Li, Chuanzhong Huang

    Diterbitkan 2024-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: